MXPA05009526A - Uso de virus de mixoma para el tratamiento terapeutico de cancer e infeccion viral cronica. - Google Patents
Uso de virus de mixoma para el tratamiento terapeutico de cancer e infeccion viral cronica.Info
- Publication number
- MXPA05009526A MXPA05009526A MXPA05009526A MXPA05009526A MXPA05009526A MX PA05009526 A MXPA05009526 A MX PA05009526A MX PA05009526 A MXPA05009526 A MX PA05009526A MX PA05009526 A MXPA05009526 A MX PA05009526A MX PA05009526 A MXPA05009526 A MX PA05009526A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- viral infection
- therapeutic treatment
- myxoma virus
- chronic viral
- Prior art date
Links
- 241000700562 Myxoma virus Species 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 208000036142 Viral infection Diseases 0.000 title 1
- 230000001684 chronic effect Effects 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000005860 defense response to virus Effects 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 208000009091 myxoma Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45252103P | 2003-03-07 | 2003-03-07 | |
| US45539303P | 2003-03-18 | 2003-03-18 | |
| PCT/CA2004/000341 WO2004078206A1 (en) | 2003-03-07 | 2004-03-08 | Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05009526A true MXPA05009526A (es) | 2005-12-15 |
Family
ID=32965588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05009526A MXPA05009526A (es) | 2003-03-07 | 2004-03-08 | Uso de virus de mixoma para el tratamiento terapeutico de cancer e infeccion viral cronica. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7582614B2 (enExample) |
| EP (1) | EP1601376B1 (enExample) |
| JP (2) | JP4800924B2 (enExample) |
| KR (1) | KR101116858B1 (enExample) |
| AU (1) | AU2004216928B2 (enExample) |
| CA (1) | CA2517147C (enExample) |
| IL (1) | IL170601A (enExample) |
| MX (1) | MXPA05009526A (enExample) |
| NZ (1) | NZ541951A (enExample) |
| RU (1) | RU2362584C2 (enExample) |
| WO (1) | WO2004078206A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2517147C (en) * | 2003-03-07 | 2011-06-14 | Robarts Research Institute | Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| DE102004003572A1 (de) * | 2004-01-23 | 2005-08-18 | Bavarian Nordic A/S | Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens |
| NZ577283A (en) * | 2005-03-07 | 2010-11-26 | Robarts Res Inst | Use of a Myxoma virus that does not express functional M135R |
| WO2007143538A2 (en) * | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Pike-a enhances infection by myxoma virus |
| NZ572893A (en) * | 2006-06-01 | 2011-06-30 | Robarts Res Inst | Myxoma virus mutants for cancer treatment |
| PL2717887T3 (pl) * | 2011-06-09 | 2018-06-29 | University Of Florida Research Foundation, Inc. | Sposoby leczenia lub zapobiegania chorobie przeszczep przeciw gospodarzowi |
| CN109982709A (zh) * | 2016-11-17 | 2019-07-05 | Vcn生物科学有限公司 | 病毒载体在治疗视网膜母细胞瘤中的用途 |
| CA3074901A1 (en) | 2017-09-11 | 2019-03-14 | Imba - Institut Fur Molekulare Biotechnologie Gmbh | Tumor organoid model |
| WO2019177438A1 (ko) * | 2018-03-16 | 2019-09-19 | 바이로큐어 주식회사 | 암 치료를 위한 레오바이러스 및 믹소마폭스 바이러스의 병용 |
| RU2699754C1 (ru) * | 2018-05-08 | 2019-09-09 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" | Флуоресцирующая клеточная линия глиомы и способ её получения |
| US12128099B2 (en) | 2018-05-25 | 2024-10-29 | Bioventures, Llc | Myxoma virus compositions and methods of use |
| EP3806888B1 (en) | 2018-06-12 | 2024-01-31 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
| KR102093623B1 (ko) * | 2018-08-17 | 2020-03-26 | 바이로큐어 주식회사 | 암 치료를 위한 다람쥐폭스 바이러스 및 믹소마폭스 바이러스의 병용 |
| CA3112788A1 (en) * | 2018-09-05 | 2020-03-12 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| WO2020106880A1 (en) | 2018-11-20 | 2020-05-28 | Bioventures, Llc | Cells for the production of viruses and methods of using the same |
| US11591616B1 (en) | 2019-04-22 | 2023-02-28 | Colorado State University Research Foundation | Apoptotic upregulation by myxoma virus expressing walleye dermal sarcoma virus orfC |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806347A (en) | 1985-12-11 | 1989-02-21 | Schering Corporation | Interferon combinations |
| GB9415320D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | Cancer treatment |
| WO1997026904A1 (en) | 1996-01-25 | 1997-07-31 | Medical Research Council | Treatment of non-neuronal cancer using hsv mutant |
| WO1999004026A2 (en) | 1997-07-18 | 1999-01-28 | Chiron Corporation | Lentiviral vectors |
| AU9603898A (en) | 1997-10-09 | 1999-05-03 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| ES2153284B1 (es) | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| CA2370187C (en) | 1999-04-15 | 2011-08-02 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| EP1200595A2 (en) * | 1999-07-12 | 2002-05-02 | Viron Therapeutics, Inc. | Myxoma virus genes for immune modulation |
| CA2517147C (en) * | 2003-03-07 | 2011-06-14 | Robarts Research Institute | Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| WO2007143545A2 (en) | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Tnf signaling in myxoma virus treatments |
-
2004
- 2004-03-08 CA CA2517147A patent/CA2517147C/en not_active Expired - Fee Related
- 2004-03-08 JP JP2006504071A patent/JP4800924B2/ja not_active Expired - Fee Related
- 2004-03-08 MX MXPA05009526A patent/MXPA05009526A/es active IP Right Grant
- 2004-03-08 EP EP04718235A patent/EP1601376B1/en not_active Expired - Lifetime
- 2004-03-08 AU AU2004216928A patent/AU2004216928B2/en not_active Ceased
- 2004-03-08 US US10/547,859 patent/US7582614B2/en not_active Expired - Fee Related
- 2004-03-08 RU RU2005131020/15A patent/RU2362584C2/ru not_active IP Right Cessation
- 2004-03-08 WO PCT/CA2004/000341 patent/WO2004078206A1/en not_active Ceased
- 2004-03-08 NZ NZ541951A patent/NZ541951A/en not_active IP Right Cessation
-
2005
- 2005-08-31 IL IL170601A patent/IL170601A/en unknown
- 2005-09-07 KR KR1020057016740A patent/KR101116858B1/ko not_active Expired - Fee Related
-
2009
- 2009-08-28 US US12/549,939 patent/US8227440B2/en not_active Expired - Fee Related
-
2011
- 2011-05-19 JP JP2011112835A patent/JP2011157399A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| NZ541951A (en) | 2008-03-28 |
| HK1081099A1 (en) | 2006-05-12 |
| WO2004078206A1 (en) | 2004-09-16 |
| RU2362584C2 (ru) | 2009-07-27 |
| US7582614B2 (en) | 2009-09-01 |
| JP2006519789A (ja) | 2006-08-31 |
| AU2004216928C1 (en) | 2007-03-08 |
| US8227440B2 (en) | 2012-07-24 |
| US20090317362A1 (en) | 2009-12-24 |
| EP1601376B1 (en) | 2012-05-30 |
| CA2517147A1 (en) | 2004-09-16 |
| IL170601A (en) | 2010-11-30 |
| RU2005131020A (ru) | 2006-03-10 |
| EP1601376A1 (en) | 2005-12-07 |
| JP4800924B2 (ja) | 2011-10-26 |
| US20060263333A1 (en) | 2006-11-23 |
| CA2517147C (en) | 2011-06-14 |
| KR20050111349A (ko) | 2005-11-24 |
| KR101116858B1 (ko) | 2012-03-06 |
| AU2004216928B2 (en) | 2007-03-08 |
| AU2004216928A1 (en) | 2004-09-16 |
| JP2011157399A (ja) | 2011-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05009526A (es) | Uso de virus de mixoma para el tratamiento terapeutico de cancer e infeccion viral cronica. | |
| WO2009091388A3 (en) | Triazines and related compounds having antiviral activity, compositions and methods thereof | |
| WO2010118367A3 (en) | Antiviral pyrimidines | |
| EA200601575A1 (ru) | Казеиновые пептиды и их терапевтическое применение | |
| MY201105A (en) | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus | |
| WO2008096831A1 (ja) | 癌の治療剤 | |
| TW200510343A (en) | Substituted dihydroquinazolines | |
| WO2008024843A3 (en) | Combination therapy method for treating hepatitis c virus infection and pharmaceutical compositions for use therein | |
| WO2006050489A3 (en) | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions | |
| WO2006133099A3 (en) | Sirna microbicides for preventing and treating viral diseases | |
| MX2021010145A (es) | Derivados de amida utiles en el tratamiento de una infeccion por vhb o de enfermedades inducidas por vhb. | |
| MX2022001261A (es) | Derivados de dihidropirimidina y usos de los mismos en el tratamiento de infeccion por vhb o de enfermedades inducidas por vhb. | |
| MX2007010962A (es) | Uso de una combinacion de virus myxoma y rapamicina para tratamiento terapeutico. | |
| TW200633995A (en) | Andrographolide derivatives to treat viral infections | |
| SE0300034D0 (sv) | Use of strains of the parapox ovis virus for producting antiviral pharmaceuticals and anticancer pharmaceuticals | |
| KR20040078639A (ko) | 카세인 유도 펩타이드 및 이들의 치료 용도 | |
| EA201101036A1 (ru) | Применение хлорида аммония в терапии | |
| WO2004052905A3 (en) | Antiviral nucleoside derivatives | |
| WO2007029041A3 (en) | Interferon lambda therapy for treatment of respiratory diseases | |
| WO2002026249A3 (en) | Methods for inhibition of viral infection | |
| WO2004018002A3 (en) | Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells | |
| MX2022001271A (es) | Derivados de dihidropirimidina y usos de estos en el tratamiento de la infeccion por vhb o de enfermedades inducidas por vhb. | |
| IN2011KN02819A (enExample) | ||
| WO2003017943A3 (en) | Therapeutic compositions and methods for treating viral infection | |
| WO2003015714A3 (en) | Compositions and therapeutic methods for viral infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |